#BrentSaunders' second stint as chief executive of eye care company #Bausch+Lomb has come to an end.
@pharmaphorum.bsky.social
@pharmaphorum.bsky.social#BrentSaunders' second stint as chief executive of eye care company #Bausch+Lomb has come to an end.
@pharmalot.bsky.socialPharmalot.. Pharmalittle.. Good Morning: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more news.. statnews.com/pharmalot/20... #pharma #obesity #antibiotic #jobs #China #weight #Novo #Roche #Merck #AstraZeneca #Baltimore #Bausch